Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3.80% is 93% above its 5-year average of -57.94%, around the middle of its 5-year range (-102.08%–73.68%).
78.54% above its 12-month average of -17.71%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 23.16%.
NET PROFIT MARGIN
-3.80%
NET PROFIT MARGIN AVG TTM
-17.71%
NET PROFIT MARGIN AVG 3Y
-31.39%
NET PROFIT MARGIN AVG 5Y
-57.94%
NET PROFIT MARGIN AVG 10Y
-68.05%
NET PROFIT MARGIN AVG 15Y
-88.56%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+78.54%
CURRENT VS 3Y AVG
+87.89%
CURRENT VS 5Y AVG
+93.44%
CURRENT VS 10Y AVG
+94.42%
CURRENT VS 15Y AVG
+95.71%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.04%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
-9400.00%
vs the sector median at left
PTC Therapeutics, Inc.
Market Cap
$5.32B
Net Profit Margin
-3.80%
TTM Avg
-17.71%
3Y Avg
-31.39%
5Y Avg
-57.94%
Market Cap
$5.27B
Net Profit Margin
25.48%
TTM Avg
34.77%
3Y Avg
31.87%
5Y Avg
32.80%
Market Cap
$5.25B
Net Profit Margin
-3368.72%
TTM Avg
-8808.10%
3Y Avg
-41695.11%
5Y Avg
-35876.65%
Market Cap
$5.24B
Net Profit Margin
13.44%
TTM Avg
5.37%
3Y Avg
-1.91%
5Y Avg
0.03%
Market Cap
$5.17B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-158.41%
Market Cap
$5.16B
Net Profit Margin
-7.35%
TTM Avg
-71.56%
3Y Avg
-118.55%
5Y Avg
-116.04%
Market Cap
$5.50B
Net Profit Margin
-10.21%
TTM Avg
-9.94%
3Y Avg
-7.18%
5Y Avg
-7.18%
Market Cap
$5.06B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.32B | -3.80% | -17.71% | -31.39% | -57.94% |
| Doximity, Inc. (DOCS)vs › | $5.27B | 25.48% | 34.77% | 31.87% | 32.80% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.25B | -3368.72% | -8808.10% | -41695.11% | -35876.65% |
| Sotera Health Company (SHC)vs › | $5.24B | 13.44% | 5.37% | -1.91% | 0.03% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | 0.00% | 0.00% | 0.00% | -158.41% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.16B | -7.35% | -71.56% | -118.55% | -116.04% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.50B | -10.21% | -9.94% | -7.18% | -7.18% |
| RadNet, Inc. (RDNT)vs › | $5.54B | -0.93% | -0.38% | 0.04% | 0.11% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | 0.00% | 0.00% | -101.30% | -277.86% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 9.22% | 8.68% | 7.83% | 5.80% |
Operating Margin
49.5%
Net Profit Margin
-3.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 23.16% |
| 2026-03-31 | -1.03% |
| 2025-12-31 | -81.96% |
| 2025-09-30 | 7.53% |
| 2025-06-30 | -36.25% |
| 2025-03-31 | 73.68% |
| 2024-12-31 | -30.91% |
| 2024-09-30 | -54.20% |
| 2024-06-30 | -53.12% |
| 2024-03-31 | -43.58% |
| 2023-12-31 | -50.74% |
| 2023-09-30 | -67.64% |
| 2023-06-30 | -93.02% |
| 2023-03-31 | -63.05% |
| 2022-12-31 | -102.08% |
| 2022-09-30 | -50.35% |
| 2022-06-30 | -91.88% |
| 2022-03-31 | -85.20% |
| 2021-12-31 | -86.71% |
| 2021-09-30 | -96.31% |
| 2021-06-30 | -101.45% |
| 2021-03-31 | -109.07% |
| 2020-12-31 | -62.55% |
| 2020-09-30 | -58.86% |
| 2020-06-30 | -241.13% |
| 2020-03-31 | -165.09% |
| 2019-12-31 | -80.53% |
| 2019-09-30 | -84.01% |
| 2019-06-30 | -48.86% |
| 2019-03-31 | -134.58% |
| 2018-12-31 | -55.98% |
| 2018-09-30 | -95.11% |
| 2018-06-30 | -13.85% |
| 2018-03-31 | -34.36% |
| 2017-12-31 | 1.63% |
| 2017-09-30 | -80.61% |
| 2017-06-30 | -36.44% |
| 2017-03-31 | -109.45% |
| 2016-12-31 | -106.37% |
| 2016-09-30 | -152.99% |
| 2016-06-30 | -248.92% |
| 2016-03-31 | -218.22% |
| 2015-12-31 | -400.09% |
| 2015-09-30 | -442.22% |
| 2015-06-30 | -602.40% |
| 2015-03-31 | -701.22% |
| 2014-12-31 | -235.04% |
| 2014-09-30 | -3423.09% |
| 2014-06-30 | -1770.38% |
| 2014-03-31 | -154.13% |
| 2013-12-31 | -455.02% |
| 2013-09-30 | -28.58% |
| 2013-06-30 | -248.59% |
| 2013-03-31 | -241.83% |
| 2012-12-31 | -105.97% |
| 2012-09-30 | -120.76% |
| 2012-06-30 | -100.06% |
| 2012-03-31 | -61.36% |
